Our Pricing

Mounjaro Discount Codes UK: How to Save on Your Prescription

Searching for genuine mounjaro discount codes uk to reduce the cost of your weight loss prescription? At Cured Pharmacy, new patients can use code WEIGHTLOSSNEW for £20 off their first Mounjaro order, with transparent pricing from £124.99 and a free clinical consultation with UK-registered prescribers. Unlike promotional codes that expire quickly or come with hidden terms, our discount applies automatically at checkout to all eligible first orders.

How Mounjaro Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in the UK [1]. This dual-action mechanism sets it apart from single-pathway treatments, as tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously.

In the landmark SURMOUNT-1 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks — the highest weight loss observed in any obesity medication trial to date [1]. The dual receptor activation enhances insulin secretion, slows gastric emptying, and reduces appetite through central nervous system pathways.

Clinical trials demonstrated that tirzepatide's effects extend beyond weight reduction. Participants experienced improvements in cardiovascular risk markers, including reductions in systolic blood pressure averaging 7-10 mmHg and improvements in lipid profiles [1]. These metabolic benefits make Mounjaro particularly suitable for patients with obesity-related comorbidities, subject to prescriber assessment.

Mounjaro Pricing and Discount Codes at Cured Pharmacy

Mounjaro treatment at Cured Pharmacy starts from £124.99 for the 2.5mg starter dose, with transparent pricing displayed before you begin your clinical consultation. Our WEIGHTLOSSNEW discount code provides new patients with £20 off their first order, reducing the initial cost barrier for those beginning their weight management journey.

The final price depends on your prescribed maintenance dose, which your UK prescriber determines based on your response to treatment and clinical assessment. Mounjaro follows a dose-escalation schedule, typically starting at 2.5mg and increasing gradually to minimise gastrointestinal side effects whilst optimising weight loss outcomes [2].

Our pricing model includes the medication, UK prescriber consultation, and discreet home delivery with no hidden fees. We guarantee the lowest prices for genuine UK-licensed Mounjaro in the country, and our transparent approach means you'll see exactly what you're paying before completing any medical questionnaire.

How to Apply Your Mounjaro Discount Code

To use the WEIGHTLOSSNEW discount code, simply enter it at checkout after completing your free clinical consultation. The £20 off first order using code WEIGHTLOSSNEW

After your initial discounted order, you'll continue to benefit from our lowest price guarantee on all subsequent prescriptions. Many patients find that the long-term savings from our competitive pricing structure outweigh single-use promotional codes offered elsewhere, particularly when committing to the recommended treatment duration of 12-18 months for optimal results.

Comparing Mounjaro Discount Codes Across UK Pharmacies

When evaluating discount codes from different UK online pharmacies, it's essential to look beyond the headline percentage. Some promotional offers apply only to specific doses, exclude consultation fees, or require minimum purchase commitments that increase overall costs.

At Cured Pharmacy, our WEIGHTLOSSNEW code provides a straightforward 10% reduction on your complete first order, including the medication itself. There are no minimum order requirements, no subscription lock-ins, and no automatic renewals that charge your card without explicit consent.

We've structured our discount programme to reward new patients whilst maintaining competitive ongoing pricing. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures that promotional pricing never compromises the quality of clinical care or the authenticity of medications dispensed. Every Mounjaro pen supplied through Cured Pharmacy is sourced directly from licensed UK wholesalers and carries full MHRA approval.

Red Flags When Searching for Mounjaro Discount Codes

Be cautious of discount codes that seem too generous or come from unverified sources. Legitimate UK pharmacies operate within strict GPhC regulations and cannot offer discounts that undermine safe prescribing practices. If a promotional code promises medication without a clinical consultation, or offers prices significantly below wholesale cost, the pharmacy may not be operating legally.

Always verify that the pharmacy is registered with the General Pharmaceutical Council before using any discount code. You can check Cured Pharmacy's registration (GPhC 9012511) on the GPhC website to confirm our credentials as a legitimate UK-registered online pharmacy authorised to dispense prescription-only medicines.

Mounjaro vs Wegovy: Clinical Differences and Pricing

Both Mounjaro and Wegovy are injectable treatments licensed in the UK for chronic weight management, but they work through different mechanisms. Wegovy contains semaglutide, a single GLP-1 receptor agonist, whilst Mounjaro's tirzepatide activates both GLP-1 and GIP receptors simultaneously [1][2].

Head-to-head trials suggest that tirzepatide produces greater average weight loss than semaglutide at comparable doses. In the SURPASS-2 trial, participants on tirzepatide 15mg lost an average of 12.4kg compared to 6.2kg with semaglutide 1mg over 40 weeks [3]. However, individual responses vary considerably, and some patients may achieve better results or experience fewer side effects with semaglutide-based treatment.

Wegovy at Cured Pharmacy is priced from £124.99, making it a more accessible option for patients who meet the clinical criteria but have budget constraints. Your UK prescriber will discuss both options during your consultation, considering factors including your weight loss goals, medical history, previous treatment responses, and cost considerations to recommend the most appropriate medication.

Who Can Use Mounjaro in the UK

Mounjaro is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [4]. These criteria align with NICE guidelines for prescribing weight management medications in primary care.

Your UK prescriber will assess your eligibility during the free online consultation, which takes under three minutes to complete. The assessment covers your medical history, current medications, previous weight loss attempts, and any contraindications to GLP-1 receptor agonist therapy. Mounjaro is not suitable for patients with a personal or family history of medullary thyroid carcinoma, or those with multiple endocrine neoplasia syndrome type 2.

Pregnant or breastfeeding women cannot use Mounjaro, and the medication should be discontinued at least two months before planned conception due to the long half-life of tirzepatide. Women of childbearing potential should use reliable contraception throughout treatment, as significant weight loss can affect the efficacy of hormonal contraceptives.

Starting Your Mounjaro Treatment

Treatment begins with the 2.5mg dose administered once weekly via subcutaneous injection. Your prescriber will provide a dose-escalation schedule, typically increasing to 5mg after four weeks, then to 7.5mg, 10mg, 12.5mg, and finally 15mg at four-week intervals [2]. This gradual titration minimises gastrointestinal side effects whilst allowing your body to adjust to the medication's effects.

Most patients reach their maintenance dose within 16-20 weeks of starting treatment. Clinical trials indicate that maximum weight loss typically occurs between 60-72 weeks of continuous therapy, so commitment to long-term treatment is essential for optimal results [1]. Your prescriber will schedule regular reviews to monitor your progress and adjust your dose if needed.

Common Side Effects and How to Manage Them

The most frequently reported side effects of Mounjaro are gastrointestinal, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort. In clinical trials, these symptoms were typically mild to moderate in severity and decreased over time as patients adjusted to treatment [1]. The dose-escalation schedule is specifically designed to minimise these effects.

To reduce nausea, patients should eat smaller, more frequent meals and avoid high-fat foods, which slow gastric emptying further. Staying well-hydrated is essential, particularly if experiencing vomiting or diarrhoea. Some patients find that injecting Mounjaro in the evening reduces daytime nausea, though you should maintain a consistent injection day each week.

Rare but serious side effects include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients also taking other diabetes medications). Seek immediate medical attention if you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction. Your prescriber will provide comprehensive safety information and guidance on when to seek urgent medical care during your consultation.

When to Contact Your Prescriber

Contact your prescriber if side effects persist beyond the first few weeks of each dose increase, or if they significantly impact your quality of life. Your dose may need to be adjusted, or your prescriber may recommend additional medications to manage specific symptoms. Never increase your dose faster than prescribed, even if you're tolerating the current dose well, as this increases the risk of adverse effects.

Regular monitoring is essential throughout treatment. Your prescriber will want to review your progress every 12 weeks to assess weight loss, evaluate side effects, and determine whether continuing treatment remains clinically appropriate. NICE guidelines recommend discontinuing treatment if patients haven't achieved at least 5% weight loss after six months at the maintenance dose.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/14819
3. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
4. National Institute for Health and Care Excellence. (2023). Tirzepatide for managing overweight and obesity. Technology appraisal guidance [TA1096]. https://www.nice.org.uk/guidance/ta1096

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro is a prescription-only medicine that must be prescribed by a qualified UK clinician following an appropriate clinical consultation.